Net profit of Kilitch Drugs (India) rose 81.86% to Rs 8.62 crore in the quarter ended September 2024 as against Rs 4.74 crore during the previous quarter ended September 2023. Sales rose 15.22% to Rs 47.47 crore in the quarter ended September 2024 as against Rs 41.20 crore during the previous quarter ended September 2023.
| Particulars | Quarter Ended |
| Sep. 2024 | Sep. 2023 | % Var. |
| Sales | 47.47 | 41.20 | 15 |
| OPM % | 12.85 | 20.92 | - |
| PBDT | 10.95 | 7.60 | 44 |
| PBT | 10.35 | 6.78 | 53 |
| NP | 8.62 | 4.74 | 82 |